T2 Biosystems Stock Technical Analysis
| TTOO Stock | USD 0 0.0007 46.67% |
As of the 14th of February 2026, T2 Biosystems owns the market risk adjusted performance of (1.07), and Standard Deviation of 161.84. In connection with fundamental indicators, the technical analysis model makes it possible for you to check timely technical drivers of T2 Biosystems, as well as the relationship between them.
T2 Biosystems Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as TTOO, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TTOOTTOO |
T2 Biosystems 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to T2 Biosystems' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of T2 Biosystems.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in T2 Biosystems on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding T2 Biosystems or generate 0.0% return on investment in T2 Biosystems over 90 days. T2 Biosystems is related to or competes with Unidoc Health, and Devonian Health. T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United ... More
T2 Biosystems Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure T2 Biosystems' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess T2 Biosystems upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 45.62 | |||
| Information Ratio | 0.176 | |||
| Maximum Drawdown | 1185.0 | |||
| Value At Risk | (81.82) | |||
| Potential Upside | 100.0 |
T2 Biosystems Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for T2 Biosystems' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as T2 Biosystems' standard deviation. In reality, there are many statistical measures that can use T2 Biosystems historical prices to predict the future T2 Biosystems' volatility.| Risk Adjusted Performance | 0.1523 | |||
| Jensen Alpha | 30.12 | |||
| Total Risk Alpha | 16.51 | |||
| Sortino Ratio | 0.6241 | |||
| Treynor Ratio | (1.08) |
T2 Biosystems February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1523 | |||
| Market Risk Adjusted Performance | (1.07) | |||
| Mean Deviation | 65.68 | |||
| Semi Deviation | 25.7 | |||
| Downside Deviation | 45.62 | |||
| Coefficient Of Variation | 566.95 | |||
| Standard Deviation | 161.84 | |||
| Variance | 26190.99 | |||
| Information Ratio | 0.176 | |||
| Jensen Alpha | 30.12 | |||
| Total Risk Alpha | 16.51 | |||
| Sortino Ratio | 0.6241 | |||
| Treynor Ratio | (1.08) | |||
| Maximum Drawdown | 1185.0 | |||
| Value At Risk | (81.82) | |||
| Potential Upside | 100.0 | |||
| Downside Variance | 2081.53 | |||
| Semi Variance | 660.69 | |||
| Expected Short fall | (139.95) | |||
| Skewness | 5.35 | |||
| Kurtosis | 31.83 |
T2 Biosystems Backtested Returns
T2 Biosystems is out of control given 3 months investment horizon. T2 Biosystems retains Efficiency (Sharpe Ratio) of 0.19, which indicates the company had a 0.19 % return per unit of price deviation over the last 3 months. We were able to break down and interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 29.25% are justified by taking the suggested risk. Use T2 Biosystems market risk adjusted performance of (1.07), and Standard Deviation of 161.84 to evaluate company specific risk that cannot be diversified away. T2 Biosystems holds a performance score of 14 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -26.47, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning T2 Biosystems are expected to decrease by larger amounts. On the other hand, during market turmoil, T2 Biosystems is expected to outperform it. Use T2 Biosystems information ratio and the relationship between the value at risk and period momentum indicator , to analyze future returns on T2 Biosystems.
Auto-correlation | 0.19 |
Very weak predictability
T2 Biosystems has very weak predictability. Overlapping area represents the amount of predictability between T2 Biosystems time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of T2 Biosystems price movement. The serial correlation of 0.19 indicates that over 19.0% of current T2 Biosystems price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
T2 Biosystems technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
T2 Biosystems Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for T2 Biosystems across different markets.
About T2 Biosystems Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of T2 Biosystems on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of T2 Biosystems based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on T2 Biosystems price pattern first instead of the macroeconomic environment surrounding T2 Biosystems. By analyzing T2 Biosystems's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of T2 Biosystems's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to T2 Biosystems specific price patterns or momentum indicators. Please read more on our technical analysis page.
T2 Biosystems February 14, 2026 Technical Indicators
Most technical analysis of TTOO help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for TTOO from various momentum indicators to cycle indicators. When you analyze TTOO charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1523 | |||
| Market Risk Adjusted Performance | (1.07) | |||
| Mean Deviation | 65.68 | |||
| Semi Deviation | 25.7 | |||
| Downside Deviation | 45.62 | |||
| Coefficient Of Variation | 566.95 | |||
| Standard Deviation | 161.84 | |||
| Variance | 26190.99 | |||
| Information Ratio | 0.176 | |||
| Jensen Alpha | 30.12 | |||
| Total Risk Alpha | 16.51 | |||
| Sortino Ratio | 0.6241 | |||
| Treynor Ratio | (1.08) | |||
| Maximum Drawdown | 1185.0 | |||
| Value At Risk | (81.82) | |||
| Potential Upside | 100.0 | |||
| Downside Variance | 2081.53 | |||
| Semi Variance | 660.69 | |||
| Expected Short fall | (139.95) | |||
| Skewness | 5.35 | |||
| Kurtosis | 31.83 |
T2 Biosystems February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as TTOO stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.47 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 |
Other Information on Investing in TTOO Pink Sheet
T2 Biosystems financial ratios help investors to determine whether TTOO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTOO with respect to the benefits of owning T2 Biosystems security.